Best TWAS P=2.42e-26 · Best GWAS P=5.78e-46 conditioned to NaN
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | AAGAB | 0.06 | 0.05 | enet | 11 | 0.05 | 3.2e-07 | 5.94 | 6.3 | 3.4e-10 | -0.15 | 1.00 | 0.00 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | DENND4A | 0.06 | 0.05 | enet | 18 | 0.05 | 7.1e-07 | -9.50 | -7.9 | 2.1e-15 | -0.03 | 0.75 | 0.25 | FALSE |
3 | CommonMind | Brain Pre-frontal Cortex | IQCH | 0.13 | 0.11 | bslmm | 597 | 0.10 | 5.9e-12 | 6.81 | -5.7 | 1.2e-08 | 0.18 | 1.00 | 0.00 | TRUE |
4 | CommonMind | Brain Pre-frontal Cortex | SLC24A1 | 0.05 | 0.03 | lasso | 7 | 0.03 | 3.0e-04 | -9.54 | -8.0 | 8.9e-16 | -0.08 | 0.63 | 0.22 | FALSE |
5 | GTEx | Adipose Visceral Omentum | PTPLAD1 | 0.13 | 0.10 | enet | 20 | 0.08 | 5.6e-05 | -8.30 | -8.4 | 3.4e-17 | -0.07 | 0.27 | 0.58 | FALSE |
6 | GTEx | Artery Tibial | DENND4A | 0.05 | 0.01 | enet | 8 | 0.02 | 8.3e-03 | -10.30 | -10.4 | 1.5e-25 | -0.08 | 0.07 | 0.81 | FALSE |
7 | GTEx | Brain Cerebellar Hemisphere | IGDCC4 | 0.19 | 0.12 | lasso | 7 | 0.10 | 1.2e-03 | -9.35 | 8.5 | 2.3e-17 | 0.08 | 0.33 | 0.31 | FALSE |
8 | GTEx | Brain Cerebellum | IGDCC4 | 0.28 | 0.27 | lasso | 5 | 0.24 | 9.6e-08 | -7.79 | 8.7 | 2.5e-18 | 0.08 | 0.57 | 0.32 | FALSE |
9 | GTEx | Brain Cerebellum | MAP2K5 | 0.27 | 0.12 | lasso | 5 | 0.14 | 7.9e-05 | 6.83 | -5.4 | 6.0e-08 | 0.11 | 0.49 | 0.03 | FALSE |
10 | GTEx | Brain Nucleus accumbens basal ganglia | DENND4A | 0.16 | 0.09 | lasso | 4 | 0.06 | 8.8e-03 | -10.46 | -10.6 | 2.4e-26 | -0.08 | 0.01 | 0.92 | TRUE |
11 | GTEx | Cells EBV-transformed lymphocytes | PTPLAD1 | 0.18 | 0.18 | enet | 25 | 0.15 | 1.7e-05 | -8.04 | 7.9 | 2.1e-15 | 0.08 | 0.29 | 0.65 | FALSE |
12 | GTEx | Cells Transformed fibroblasts | DENND4A | 0.08 | 0.06 | lasso | 2 | 0.04 | 3.3e-04 | -9.35 | 9.3 | 8.8e-21 | 0.06 | 0.62 | 0.25 | FALSE |
13 | GTEx | Muscle Skeletal | IGDCC4 | 0.03 | 0.01 | lasso | 2 | 0.02 | 9.2e-03 | -8.45 | 7.3 | 3.2e-13 | 0.08 | 0.20 | 0.37 | FALSE |
14 | GTEx | Muscle Skeletal | SMAD3 | 0.13 | 0.10 | enet | 8 | 0.10 | 4.2e-10 | -7.44 | -8.4 | 3.2e-17 | 0.09 | 1.00 | 0.00 | TRUE |
15 | GTEx | Pituitary | DENND4A | 0.19 | 0.12 | enet | 9 | 0.10 | 1.5e-03 | -7.68 | -8.5 | 2.1e-17 | -0.07 | 0.13 | 0.42 | FALSE |
16 | GTEx | Skin Sun Exposed Lower leg | IGDCC4 | 0.05 | 0.00 | enet | 9 | 0.00 | 6.1e-01 | -8.16 | 6.6 | 4.4e-11 | 0.03 | 0.04 | 0.05 | FALSE |
17 | GTEx | Testis | DPP8 | 0.09 | 0.03 | lasso | 3 | 0.04 | 5.3e-03 | -2.98 | 5.5 | 2.9e-08 | 0.06 | 0.06 | 0.58 | FALSE |
18 | GTEx | Whole Blood | MAP2K5 | 0.09 | 0.06 | lasso | 6 | 0.06 | 8.1e-06 | 3.19 | -5.6 | 2.7e-08 | 0.11 | 0.84 | 0.00 | TRUE |
19 | METSIM | Adipose | PARP16 | 0.03 | 0.01 | bslmm | 327 | 0.01 | 2.8e-03 | 0.66 | 6.9 | 4.6e-12 | 0.05 | 0.04 | 0.28 | FALSE |
20 | METSIM | Adipose | SMAD3 | 0.09 | 0.01 | lasso | 4 | 0.01 | 4.1e-03 | -8.43 | 6.5 | 8.7e-11 | -0.55 | 0.02 | 0.91 | TRUE |
21 | YFS | Blood | SLC24A1 | 0.06 | 0.02 | bslmm | 339 | 0.03 | 5.8e-10 | -10.46 | 5.7 | 1.4e-08 | 0.09 | 0.00 | 1.00 | FALSE |
22 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | DPP8 | 0.07 | 0.00 | enet | 9 | 0.03 | 2.9e-03 | 1.04 | 6.0 | 2.0e-09 | 0.05 | 0.01 | 0.80 | FALSE |
23 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | IQCH | 0.13 | 0.07 | blup | 112 | 0.10 | 5.2e-09 | 6.31 | -7.0 | 3.3e-12 | 0.22 | 0.18 | 0.81 | FALSE |
24 | The Cancer Genome Atlas | Breast Invasive Carcinoma | DENND4A | 0.01 | 0.01 | blup | 68 | 0.01 | 7.5e-03 | -7.58 | 6.4 | 1.2e-10 | 0.04 | 0.03 | 0.16 | FALSE |
25 | The Cancer Genome Atlas | Breast Invasive Carcinoma | DPP8 | 0.08 | 0.02 | lasso | 4 | 0.05 | 6.1e-10 | -10.46 | 7.9 | 2.0e-15 | 0.05 | 0.00 | 1.00 | FALSE |
26 | The Cancer Genome Atlas | Breast Invasive Carcinoma | IQCH | 0.06 | 0.05 | blup | 112 | 0.06 | 5.2e-12 | 6.97 | -7.3 | 2.5e-13 | 0.23 | 0.07 | 0.93 | TRUE |
27 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | PTPLAD1 | 0.09 | 0.06 | blup | 46 | 0.06 | 5.2e-04 | 6.64 | 9.7 | 3.6e-22 | 0.08 | 0.05 | 0.52 | FALSE |
28 | The Cancer Genome Atlas | Colon Adenocarcinoma | IQCH | 0.08 | 0.02 | blup | 111 | 0.05 | 4.2e-04 | 6.36 | -7.5 | 7.5e-14 | 0.21 | 0.16 | 0.67 | TRUE |
29 | The Cancer Genome Atlas | Glioblastoma Multiforme | DPP8 | 0.25 | 0.14 | enet | 6 | 0.12 | 1.8e-04 | 1.04 | 5.4 | 8.4e-08 | 0.04 | 0.01 | 0.73 | FALSE |
30 | The Cancer Genome Atlas | Glioblastoma Multiforme | IQCH | 0.19 | 0.14 | enet | 21 | 0.12 | 2.4e-04 | 6.36 | -6.7 | 1.6e-11 | 0.20 | 0.21 | 0.59 | FALSE |
31 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | IQCH | 0.06 | 0.04 | blup | 111 | 0.03 | 1.0e-04 | 6.36 | -6.2 | 6.3e-10 | 0.23 | 0.27 | 0.47 | FALSE |
32 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | PTPLAD1 | 0.05 | 0.01 | enet | 10 | 0.02 | 4.3e-03 | 0.67 | 5.9 | 4.5e-09 | 0.03 | 0.04 | 0.16 | FALSE |
33 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | DPP8 | 0.03 | 0.01 | blup | 53 | 0.01 | 8.4e-03 | -7.79 | 10.4 | 4.1e-25 | 0.09 | 0.01 | 0.86 | FALSE |
34 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | IQCH | 0.12 | 0.10 | enet | 22 | 0.12 | 4.0e-13 | 6.33 | -7.0 | 2.4e-12 | 0.25 | 0.84 | 0.16 | TRUE |
35 | The Cancer Genome Atlas | Brain Lower Grade Glioma | IQCH | 0.05 | 0.04 | blup | 111 | 0.04 | 7.7e-06 | 6.31 | -6.9 | 5.2e-12 | 0.25 | 0.15 | 0.83 | FALSE |
36 | The Cancer Genome Atlas | Lung Adenocarcinoma | DPP8 | 0.07 | 0.01 | blup | 53 | 0.03 | 1.7e-04 | 0.99 | 6.5 | 9.8e-11 | 0.05 | 0.02 | 0.91 | FALSE |
37 | The Cancer Genome Atlas | Lung Adenocarcinoma | IQCH | 0.04 | 0.02 | enet | 8 | 0.01 | 1.6e-02 | 4.31 | -5.1 | 2.9e-07 | 0.22 | 0.13 | 0.07 | FALSE |
38 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | IQCH | 0.04 | 0.02 | enet | 6 | 0.03 | 1.6e-04 | 3.27 | -6.2 | 7.8e-10 | 0.19 | 0.09 | 0.81 | TRUE |
39 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | DENND4A | 0.04 | 0.02 | blup | 67 | 0.02 | 1.3e-02 | -10.19 | 9.1 | 7.7e-20 | 0.06 | 0.01 | 0.71 | FALSE |
40 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | IQCH | 0.11 | 0.10 | blup | 112 | 0.10 | 2.3e-07 | 4.28 | -6.7 | 2.2e-11 | 0.23 | 0.49 | 0.50 | FALSE |
41 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | IQCH | 0.35 | 0.04 | blup | 112 | 0.12 | 1.5e-05 | 6.31 | -7.4 | 1.5e-13 | 0.21 | 0.14 | 0.72 | FALSE |
42 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | DPP8 | 0.08 | 0.04 | blup | 53 | 0.06 | 2.2e-03 | -8.09 | 9.4 | 3.5e-21 | 0.08 | 0.06 | 0.42 | FALSE |
43 | The Cancer Genome Atlas | Prostate Adenocarcinoma | DPP8 | 0.08 | 0.08 | lasso | 4 | 0.07 | 1.6e-07 | -10.49 | 10.2 | 2.2e-24 | 0.09 | 0.00 | 1.00 | FALSE |
44 | The Cancer Genome Atlas | Rectum Adenocarcinoma | DENND4A | 0.17 | 0.08 | blup | 68 | 0.07 | 1.0e-02 | -10.19 | 10.3 | 1.2e-24 | 0.08 | 0.03 | 0.68 | FALSE |
45 | The Cancer Genome Atlas | Soft Tissue Sarcoma | DPP8 | 0.16 | 0.01 | blup | 53 | 0.03 | 9.7e-03 | 1.09 | 6.3 | 2.7e-10 | 0.05 | 0.01 | 0.29 | FALSE |
46 | The Cancer Genome Atlas | Soft Tissue Sarcoma | IQCH | 0.08 | 0.09 | enet | 8 | 0.08 | 2.3e-05 | 6.36 | -6.0 | 1.7e-09 | 0.18 | 0.59 | 0.20 | TRUE |
47 | The Cancer Genome Atlas | Stomach Adenocarcinoma | IQCH | 0.08 | 0.03 | blup | 111 | 0.04 | 9.2e-04 | 6.31 | -6.7 | 2.6e-11 | 0.21 | 0.07 | 0.34 | FALSE |
48 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | DENND4A | 0.09 | 0.05 | lasso | 4 | 0.03 | 3.3e-02 | -9.35 | 9.1 | 1.3e-19 | 0.05 | 0.04 | 0.32 | FALSE |
49 | The Cancer Genome Atlas | Thyroid Carcinoma | DPP8 | 0.05 | 0.02 | lasso | 5 | 0.04 | 5.9e-05 | -10.49 | 9.7 | 3.4e-22 | 0.10 | 0.00 | 0.99 | FALSE |
50 | The Cancer Genome Atlas | Thyroid Carcinoma | IQCH | 0.15 | 0.17 | enet | 19 | 0.17 | 1.3e-16 | 6.33 | -6.7 | 2.2e-11 | 0.22 | 0.77 | 0.23 | TRUE |